Cancer Research UK announces new top seed

Governance | Niki May Young | 7 Apr 2010

The Charity 100 Index number two is set for a new top seed with the announcement that former chief executive of plant technology firm Syngenta, Michael Pragnell, is to succeed David Newbigging as chairman of Cancer Research UK.

Pragnell (pictured), who is expected to take up the position in November this year, was the founder and chief executive of Syngenta AG, a world-leading company in crop protection and plant bioscience which now employs more than 25,000 people in 90 countries. Prior to this he was CEO of AstraZeneca’s crop protection business.

Cancer Research UK also announces the appointment of Professor Anton Berns as a trustee to the charity. Berns is director of research at the Netherlands Cancer Institute and professor of experimental genetics of inherited diseases at the University of Amsterdam.

“We’re delighted to welcome Michael Pragnell and Professor Berns to our council,” said Newbigging.

“Michael joins our council after an outstandingly successful career as chief executive of Syngenta, prior to which he was with AstraZeneca and before that Courtaulds. In addition, he has considerable international experience having worked in the US and Continental Europe as well as in the UK.

“Anton Berns is well known to us and has served as a non-trustee member of our Council Research Strategy Committee which oversees the research strategy of the charity. He has also served on a number of committees associated with us and we are fortunate to have such an eminent internationally-acclaimed scientist on our council.”

Directory: Cancer Research UK (CRUK)
Who's Who: Niki May Young

Comments

[Cancel] | Reply to:

Name *

Email *

Organisation

Job Title

Comments *

Verification *

* Please read our Community Standards

Close »

Community Standards

The civilsociety.co.uk community and comments board is intended as a platform for informed and civilised debate.

We hope to encourage a broad range of views, however, there are standards that we expect commentators to uphold. We reserve the right to delete or amend any comments that do not adhere to these standards.

We welcome:

Robust but respectful debate
Strongly held opinions
Intelligent relevant discussion
The sharing of relevant experiences
New participants

We will not publish:

Rude, threatening, offensive, obscene or abusive language, or links to such material
Links to commercial organisations or spam postings. The comments board is not an advertising platform
The posting of contact details for yourself or others
Comments intended for malicious purpose or mindless abuse
Comments purporting to be from another person or organisation under false pretences
Gratuitous criticism, commentary or self-promotion
Any material which breaches copyright or privacy laws, or could be considered libellous
The use of the comments board for the pursuit or extension of personal disputes

Be aware:

Views expressed on the comments board are left at users’ discretion and are in no way views held or supported by Civil Society Media
Comments left by others may not be accurate, do not rely on them as fact
You may be misunderstood - sarcasm and humour can easily be taken out of context, try to be clear

Please:

Enjoy the opportunity to express your opinion and respect the right of others to express theirs
Confine your remarks to issues rather than personalities

Together we can keep our community a polite, respectful and intelligent platform for discussion.